CIK 0001401040 · Non-accelerated filer<br>Smaller reporting company
DiaMedica Therapeutics Inc.
Sign in to watch- Ticker
- DMAC
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Canada (Federal Level)
- Entity type
- operating
- Phone
- (763) 496-5454
- Business address
- 301 CARLSON PARKWAY, SUITE 210, MINNEAPOLIS, MN, 55305
- Former names
- DiaMedica Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-06-01 | Pilnik Richard D. Director | Grant or award · Stock Option (right to buy) | +18,510 | 18,510 | ||
| 2022-06-01 | Semba Charles Pauling Director | Grant or award · Stock Option (right to buy) | +13,222 | 13,222 | ||
| 2022-02-01 | Cundari Dominic R Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +125,000 | 125,000 | ||
| 2022-02-01 | Cundari Dominic R Chief Commercial Officer | Grant or award · Stock Option (right to buy) | +40,000 | 40,000 | ||
| 2022-01-03 | Gruis Kirsten L Chief Medical Officer | Grant or award · Stock Option (right to buy) | +160,000 | 160,000 | ||
| 2022-01-03 | Burroughs Amy L. Director | Grant or award | +11,182 | $3.58 | $40K | 56,132 |
| 2022-01-03 | Pilnik Richard D. Director | Grant or award | +23,762 | $3.58 | $85K | 119,327 |
| 2022-01-03 | Parsons James T. Director | Grant or award | +16,773 | $3.58 | $60K | 38,509 |
| 2022-01-03 | Giuffre Randall Michael Director | Grant or award | +15,026 | $3.58 | $54K | 110,225 |
| 2021-09-15 | ALCORN HARRY W JR SVP, Clinical Operations | Purchase | +15,000 | $3.80 | $57K | 43,582 |
| 2021-08-16 | Burroughs Amy L. Director | Purchase | +44,950 | $3.15 | $142K | 44,950 |
| 2021-08-16 | Pilnik Richard D. Director | Purchase | +2,500 | $3.21 | $8K | 83,065 |
| 2021-08-16 | Pilnik Richard D. Director | Purchase | +12,500 | $3.28 | $41K | 95,565 |
| 2021-08-16 | ALCORN HARRY W JR Senior VP, Clinical Operations | Purchase | +20,000 | $3.09 | $62K | 28,260 |
| 2021-08-16 | ALCORN HARRY W JR Senior VP, Clinical Operations | Purchase | +322 | $3.06 | $985 | 28,582 |
| 2021-08-16 | ALCORN HARRY W JR Senior VP, Clinical Operations | Purchase | +399 | $3.07 | $1K | 399 |
| 2021-08-16 | Pauls Dietrich John President and CEO | Purchase | +5,000 | $3.14 | $16K | 35,804 |
| 2021-08-16 | Kellen Scott CFO and Secretary | Purchase | +10,000 | $3.15 | $31K | 22,290 |
| 2021-07-28 | Gilman Sydney A. VP, Regulatory Affairs | Grant or award · Stock Option (right to buy) | +25,000 | 25,000 | ||
| 2021-07-28 | ALCORN HARRY W JR Chief Medical Officer | Grant or award · Stock Option (right to buy) | +60,000 | 60,000 |
Page 7 of 10 · 189 trades